Citations

Mayo Clinic

Clear

1291 citation(s) found for "Wu, Erik".

Predicting Radionuclide Bone Scan Findings in Patients with Newly Diagnosed, Untreated Prostate Cancer: Prostate Specific Antigen is Superior to All Other Clinical Parameters
Chybowski, Frank M., Keller, Jeffrey J. Larson, Bergstralh, Erik J., Oesterling, Joseph E.

Journal of Urology | June 29, 2017 | Volume: 145 | Issue: 2 | Pages: 313-318

10.1016/s0022-5347(17)38325-8 | PMID 1703240 Get It

Extended Followup of Bilateral Wilms Tumor: Results of the National Wilms Tumor Study
Montgomery, Benjamin T., Kelalis, Panayotis P., Blute, Michael L., Bergstralh, Erik J., Beckwith, J. Bruce, Norkool, Pat, D’Angio, Giulio J., Green, Daniel M.

Journal of Urology | June 29, 2017 | Volume: 146 | Issue: 2 Part 2 | Pages: 514-518

10.1016/s0022-5347(17)37840-0 | PMID 1650403 Get It

Prognosis of Children with Solitary Kidney after Unilateral Nephrectomy
Argueso, Luis R., Ritchey, Michael L., Boyle, Emmett T., Milliner, Dawn S. , Bergstralh, Erik J., Kramer, Stephen A.

Journal of Urology | June 29, 2017 | Volume: 148 | Issue: 2 Part 2 | Pages: 747-751

10.1016/s0022-5347(17)36710-1 | PMID 1640559 Get It

Prostate Specific Antigen in Hormonally Treated Stage D2 Prostate Cancer: Is it always an Accurate Indicator of Disease Status?
Leo, Mark E., Bilhartz, David L., Bergstralh, Erik J., Oesterling, Joseph E.

Journal of Urology | June 29, 2017 | Volume: 145 | Issue: 4 | Pages: 802-806

10.1016/s0022-5347(17)38456-2 | PMID 1706440 Get It

Eliminating the Need for Bilateral Pelvic Lymphadenectomy in Select Patients with Prostate Cancer
Bluestein, David L., Bostwick, David G., Bergstralh, Erik J., Oesterling, Joseph E.

Journal of Urology | June 29, 2017 | Volume: 151 | Issue: 5 | Pages: 1315-1320

10.1016/s0022-5347(17)35239-4 | PMID 7512662 Get It

The Effect of Digital Rectal Examination on the Serum Prostate Specific Antigen Concentration: Results of a Randomized Study
Chybowski, Frank M., Bergstralh, Erik J., Oesterling, Joseph E.

Journal of Urology | June 29, 2017 | Volume: 148 | Issue: 1 | Pages: 83-86

10.1016/s0022-5347(17)36517-5 | PMID 1377290 Get It

Restless mouth syndrome
Jung, Youngsin, Hassan, Anhar , Louis, Erik K. St. , Robertson, Carrie E. , St Louis, Erik K, St Louis, E K , Robertson, Carrie E

Neurology Clinical Practice | June 12, 2017 | Volume: 7 | Issue: 3 | Pages: No page available

10.1212/cpj.0000000000000280 | PMID 30107007 Get It

Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population‐based sample
Jung, Youngsin, Boot, Brendon , Mielke, Michelle M. , Ferman, Tanis J. , Geda, Yonas E. , Christianson, Teresa J., Louis, Erik K. St. , Silber, Michael H. , Petersen, Ronald C. , Christianson, Teresa J H, St Louis, Erik K, McDade, Eric , Knopman, David S. , Boeve, Bradley F. , St Louis, E K , Mielke, Michelle M , Geda, Yonas E , Ferman, Tanis J

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | May 31, 2017 | Volume: 8 | Issue: 1 | Pages: 127-130

10.1016/j.dadm.2017.05.004 | PMID 28649596 Get It

AbstractIntroductionRapid eye movement sleep behavior disorder (RBD) is strongly associated with synucleinopathies. In 2012, we reported an increased risk of mild cognitive impairment (MCI) and Parkinson disease (PD) in cognitively normal Olmsted County, Minnesota, residents, aged 70 to 89 years with probable RBD. Here, we examine their progression to dementia and other neurodegenerative phenotypes.MethodsFifteen participants with RBD who were diagnosed with either MCI or PD were longitudinally followed, and their subsequent clinical courses were reviewed.ResultsOver 6.4 ± 2.9 years, six of the 14 participants with MCI developed additional neurodegenerative signs, five of whom had Lewy body disease features. Four of them progressed to dementia at a mean age 84.8 ± 4.9 years, three of whom met the criteria for probable dementia with Lewy bodies. One subject with PD developed MCI, but not dementia.DiscussionOur findings from the population‐based sample of Olmsted County, Minnesota, residents suggest that a substantial number of RBD patients tend to develop overt synucleinopathy features over time, and RBD patients who develop MCI and subsequent dementia have clinical features most consistent with dementia with Lewy bodies.
Predictors of incident proteinuria among patients with SLE
Barr, Erik , Magder, Laurence S. , Petri, Michelle , Duarte‐García, Alí

Lupus Science & Medicine | May 23, 2017 | Volume: 4 | Issue: 1 | Pages: e000200

10.1136/lupus-2016-000200 | PMID 29177060 Get It

Objective To identify fixed and time-varying predictors of incident proteinuria. Methods This analysis was based on patients who did not have a history of diabetes and who did not have a prior episode of renal involvement. We defined an incident case of proteinuria as two or more measures of urine protein to creatinine ratio (or 24-hour protein measure) greater than 0.5 in two visits separated by more than 30 days and less than 180 days. We estimated rates of incident proteinuria in subgroups of patients with lupus defined by time-invariant and time-varying predictors. Results Among 895 patients included in the analysis, 840 (94%) were female, and 518 (58%) were Caucasian, 304 (34%) African-American, with mean age of 42 years at the start of follow-up. We observed 57 incident cases of proteinuria over a span of 4669 person-years of cohort follow-up. The overall rate of incident proteinuria was 12.2 per 1000 person-years. The rate was significantly lower among those of older age, and higher among those who were not Caucasian. In those with a very low C3 measure in a previous cohort visit, the rate was increased by a factor of 16.1 and in those with a very low C4 by 16.3. The rate among those prescribed hydroxychloroquine or ACE inhibitors/ARB was similar to those not on them. Conclusions Older patients with SLE are at low risk for developing proteinuria. There was not strong evidence that hydroxychloroquine or angiotensin-converting-enzyme (ACE) inhibitor reduced the risk of proteinuria. The highest rates of incident proteinuria were among those with recent low complement.
Effectiveness of a Decision Aid in Potentially Vulnerable Patients: A Secondary Analysis of the Chest Pain Choice Multicenter Randomized Trial
Schaffer, Jason T. , Kline, Jeffrey A. , Diercks, Deborah B. , Jones, Russell, Demers, Michel, Shah, Nilay D. , Inselman, Jonathan , Torres, Carlos A, Rising, Kristin L. , Hollander, Judd E. , Torres, Carlos A., Owen, Kelly P. , Meisel, Zachary F. , LeBlanc, Annie , Herrin, Jeph , Montori, Víctor M. , Hess, Erik P.

Medical Decision Making | May 19, 2017 | Volume: 38 | Issue: 1 | Pages: 69-78

10.1177/0272989x17706363 | PMID 28525723 Get It

Background. We test the hypotheses that use of the Chest Pain Choice (CPC) decision aid (DA) would be similarly effective in potentially vulnerable subgroups but increase knowledge more in patients with higher education and trust in physicians more in patients from racial minority groups. Methods. This was a secondary analysis of a multicenter randomized trial in adults with chest pain potentially due to acute coronary syndrome. The trial compared an intervention group engaged in shared decision making (SDM) using CPC to a control group receiving usual care (UC). We assessed for subgroup effects based on age, sex, race, income, insurance, education, literacy, and numeracy. We dichotomized each characteristic and tested for interactions using regression models with indicators for arm assignment and study site. Results. Of 898 patients (451 DA, 447 UC), over 50% were female, over one-third were black, nearly one-third had a high school education or less, and over 60% had “low” health literacy. The DA did not increase knowledge more in patients with higher education ( P for interaction = 0.06) but did increase knowledge more in the “typical” than in the “low” numeracy subgroup (10.6% v. 4.7%, absolute difference [AD] = 5.9%, P for interaction = 0.025). The DA did not significantly increase patient trust in physicians in racial minorities ( P for interaction = 0.06) but did increase trust more in patients with “low” literacy compared with those with “typical” literacy (3.7% v. –1.4%, AD = 5.1, P for interaction = 0.011). Conclusions. CPC benefited all sociodemographic groups to a similar extent, with greater knowledge transfer in patients with higher numeracy and greater physician trust in patients with “low” health literacy. Tailoring SDM interventions to patient characteristics may be necessary for optimal effectiveness.